Valeant names Howard Schiller as interim CEO

Valeant Pharmaceuticals has named former finance chief Howard Schiller as interim CEO while the troubled drug company’s chairman and chief executive remains hospitalized with severe pneumonia. Valeant said Tuesday that J. Michael Pearson is still on medical leave, and it did not know when he would return. Schiller will become interim CEO immediately and Robert […]